NM_021930.6:c.1025T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021930.6(RINT1):​c.1025T>C​(p.Met342Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000987 in 1,613,208 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M342I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00072 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 31 hom. )

Consequence

RINT1
NM_021930.6 missense

Scores

1
2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 5.55

Publications

5 publications found
Variant links:
Genes affected
RINT1 (HGNC:21876): (RAD50 interactor 1) This gene encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. The encoded protein may also play a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Mutations in this gene may be associated with breast cancer in human patients. [provided by RefSeq, Oct 2016]
RINT1 Gene-Disease associations (from GenCC):
  • infantile liver failure syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile liver failure syndrome 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012312591).
BP6
Variant 7-105550083-T-C is Benign according to our data. Variant chr7-105550083-T-C is described in ClinVar as Benign. ClinVar VariationId is 224922.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000722 (110/152346) while in subpopulation SAS AF = 0.0128 (62/4828). AF 95% confidence interval is 0.0103. There are 1 homozygotes in GnomAd4. There are 65 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 31 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RINT1NM_021930.6 linkc.1025T>C p.Met342Thr missense_variant Exon 8 of 15 ENST00000257700.7 NP_068749.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RINT1ENST00000257700.7 linkc.1025T>C p.Met342Thr missense_variant Exon 8 of 15 1 NM_021930.6 ENSP00000257700.2
RINT1ENST00000474123.1 linkn.29T>C non_coding_transcript_exon_variant Exon 1 of 4 2
RINT1ENST00000497979.5 linkn.*630T>C non_coding_transcript_exon_variant Exon 8 of 15 5 ENSP00000420582.1
RINT1ENST00000497979.5 linkn.*630T>C 3_prime_UTR_variant Exon 8 of 15 5 ENSP00000420582.1

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
110
AN:
152228
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0128
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00185
AC:
465
AN:
250982
AF XY:
0.00248
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00101
AC:
1482
AN:
1460862
Hom.:
31
Cov.:
30
AF XY:
0.00142
AC XY:
1030
AN XY:
726678
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33442
American (AMR)
AF:
0.000201
AC:
9
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.00329
AC:
86
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.0130
AC:
1116
AN:
86116
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5758
European-Non Finnish (NFE)
AF:
0.000144
AC:
160
AN:
1111342
Other (OTH)
AF:
0.00131
AC:
79
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
69
139
208
278
347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000722
AC:
110
AN:
152346
Hom.:
1
Cov.:
32
AF XY:
0.000872
AC XY:
65
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41592
American (AMR)
AF:
0.000327
AC:
5
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.0128
AC:
62
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68024
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000641
Hom.:
1
Bravo
AF:
0.000423
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00203
AC:
246
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RINT1: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jul 02, 2020
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The RINT1 p.M1? variant was not identified in the literature but was identified in dbSNP (ID: rs140651827) and ClinVar (classified as benign by Invitae). The variant was identified in control databases in 475 of 282394 chromosomes (13 homozygous) at a frequency of 0.001682, and was observed at the highest frequency in the South Asian population in 385 of 30490 chromosomes (12 homozygous) (freq: 0.01263) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.M1? variant results in the loss of the initiation codon which is predicted to lead to an absent protein and loss of function; however, the role of loss of function variants of the RINT1 gene in disease is currently not well-established. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -

RINT1-related disorder Benign:1
Feb 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
20
DANN
Benign
0.75
DEOGEN2
Benign
0.068
T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.10
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
5.6
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
0.63
N
REVEL
Benign
0.10
Sift
Benign
1.0
T
Sift4G
Uncertain
0.029
D
Polyphen
0.0030
B
Vest4
0.55
MVP
0.36
MPC
0.22
ClinPred
0.025
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.097
gMVP
0.32
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140651827; hg19: chr7-105190530; COSMIC: COSV57559291; COSMIC: COSV57559291; API